Insider Trading & Ownership - Lexeo Therapeutics Inc. (LXEO)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lexeo Therapeutics Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-10
Sale
2024-10-15
1:45 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$8.0991$40,496244,350
(Direct)
View
2024-09-10
Sale
2024-09-11
5:17 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$10.65$53,274249,350
(Direct)
View
2024-08-12
Sale
2024-08-13
6:34 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$11.53$57,635254,350
(Direct)
View
2024-07-10
Sale
2024-07-12
4:55 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
55,000$16.79$923,388259,350
(Direct)
View
2024-06-10
Sale
2024-06-12
5:00 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$17.65$88,264314,350
(Direct)
View
2024-05-13
Sale
2024-05-14
4:04 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$13.22$66,093319,350
(Direct)
View
2023-11-07
Purchase
2023-11-09
8:36 pm
Lexeo Therapeutics Inc.LXEOOmega Fund VI L.P.
Omega Fund VI GP L.P.
Omega Fund VI GP Manager Ltd.
Stampacchia Otello
Nessi Claudio
Paster Anne-Mari
10% Owner
454,545$11$4,999,9952,157,623
(Direct)
View
2023-11-07
Purchase
2023-11-09
8:33 pm
Lexeo Therapeutics Inc.LXEOLundbeckfond Invest A/S
10% Owner
227,272$11$2,499,9921,835,959
(Direct)
View
2023-11-07
Purchase
2023-11-09
8:32 pm
Lexeo Therapeutics Inc.LXEOLongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
454,545$11$4,999,9952,567,100
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-10
Exercise
2024-10-15
1:45 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33244,350
(Direct)
View
2024-10-10
Exercise
2024-10-15
1:45 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0244,350
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:17 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33249,350
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:17 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0249,350
(Direct)
View
2024-08-12
Exercise
2024-08-13
6:34 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33254,350
(Direct)
View
2024-08-12
Exercise
2024-08-13
6:34 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0254,350
(Direct)
View
2024-07-10
Exercise
2024-07-12
4:55 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33259,350
(Direct)
View
2024-07-10
Exercise
2024-07-12
4:55 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0259,350
(Direct)
View
2024-07-05
Option Award
2024-07-08
6:26 pm
N/A
2034-07-04
Lexeo Therapeutics Inc.LXEOVan Hauwermeiren Timothy
Director
36,000$036,000
(Direct)
View
2024-06-25
Option Award
2024-06-27
5:05 pm
N/A
2034-06-24
Lexeo Therapeutics Inc.LXEOCOOPERSTONE BRENDA
Director
18,000$018,000
(Direct)
View
2024-06-25
Option Award
2024-06-27
5:04 pm
N/A
2034-06-24
Lexeo Therapeutics Inc.LXEOAltschuler Steven
Director
18,000$018,000
(Direct)
View
2024-06-25
Option Award
2024-06-27
5:02 pm
N/A
2034-06-24
Lexeo Therapeutics Inc.LXEODIAZ REINALDO M
Director
18,000$018,000
(Direct)
View
2024-06-25
Option Award
2024-06-27
5:01 pm
N/A
2034-06-24
Lexeo Therapeutics Inc.LXEOCHOLMONDELEY PAULA H
Director
18,000$018,000
(Direct)
View
2024-06-25
Option Award
2024-06-27
5:01 pm
N/A
2034-06-24
Lexeo Therapeutics Inc.LXEOAgger Mette Kirstine
Director
18,000$018,000
(Direct)
View
2024-06-12
Option Award
2024-06-14
09:04 am
N/A
2034-06-11
Lexeo Therapeutics Inc.LXEOOtero Jose Manuel
Chief Technical Officer
218,750$0218,750
(Direct)
View
2024-06-10
Exercise
2024-06-12
5:00 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33314,350
(Direct)
View
2024-06-10
Exercise
2024-06-12
5:00 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0314,350
(Direct)
View
2024-05-13
Exercise
2024-05-14
4:04 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33319,350
(Direct)
View

Ownership
2024-02-06
5:58 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOSee Tai Sandi
Chief Development Officer
0$0180,564
(Direct)
View
2024-02-02
Option Award
2024-02-06
5:58 pm
N/A
2034-02-01
Lexeo Therapeutics Inc.LXEODIAZ REINALDO M
Director
36,000$036,000
(Direct)
View
2024-02-02
Option Award
2024-02-06
5:57 pm
N/A
2034-02-01
Lexeo Therapeutics Inc.LXEOAgger Mette Kirstine
Director
36,000$036,000
(Direct)
View
2024-02-02
Option Award
2024-02-06
5:56 pm
N/A
2034-02-01
Lexeo Therapeutics Inc.LXEOAdler Eric
Chief Medical Officer
188,125$0188,125
(Direct)
View
2024-01-05
Option Award
2024-01-09
6:52 pm
N/A
2034-01-04
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
306,250$0433,195
(Direct)
View
2024-01-05
Option Award
2024-01-09
6:50 pm
N/A
2034-01-04
Lexeo Therapeutics Inc.LXEORobertson Jenny
Chief Legal and Admin Officer
166,250$0166,250
(Direct)
View
2023-11-07
Conversion
2023-11-09
8:36 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOOmega Fund VI L.P.
Omega Fund VI GP L.P.
Omega Fund VI GP Manager Ltd.
Stampacchia Otello
Nessi Claudio
Paster Anne-Mari
10% Owner
19,318,610$02,157,623
(Direct)
View
2023-11-07
Conversion
2023-11-09
8:35 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOMcCormac Paul
Chief Technical Officer
32,252$017,349
(Direct)
View
2023-11-07
Conversion
2023-11-09
8:33 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOLundbeckfond Invest A/S
10% Owner
18,224,219$01,835,959
(Direct)
View
2023-11-07
Conversion
2023-11-09
8:32 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOLongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
24,018,702$02,567,100
(Indirect)
View

Ownership
2023-11-02
9:42 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
0$0906,222
(Direct)
View

Ownership
2023-11-02
9:41 pm
N/A
2032-05-05
Lexeo Therapeutics Inc.LXEORobertson Jenny
Chief Legal and Admin. Officer
0$0135,516
(Direct)
View

Ownership
2023-11-02
9:40 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOOmega Fund VI L.P.
Omega Fund VI GP L.P.
Omega Fund VI GP Manager Ltd.
Stampacchia Otello
Nessi Claudio
Paster Anne-Mari
10% Owner
0$01,662,748
(Direct)
View

Ownership
2023-11-02
9:38 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOMcCormac Paul
Chief Technical Officer
0$0184,368
(Direct)
View

Ownership
2023-11-02
9:37 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOLundbeckfond Invest A/S
10% Owner
0$01,568,357
(Direct)
View

Ownership
2023-11-02
9:36 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOLongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
0$02,067,743
(Indirect)
View

Ownership
2023-11-02
9:19 pm
N/A
2033-08-21
Lexeo Therapeutics Inc.LXEOCOOPERSTONE BRENDA
Director
0$059,812
(Direct)
View

Ownership
2023-11-02
9:17 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOCHOLMONDELEY PAULA H
Director
0$059,811
(Direct)
View

Ownership
2023-11-02
9:16 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOAltschuler Steven
Director
0$0119,625
(Direct)
View

Ownership
2023-11-02
9:14 pm
N/A
2031-11-03
Lexeo Therapeutics Inc.LXEOAdler Eric
Chief Scientific Officer
0$0256,679
(Direct)
View